ravulizumab
0 sources
ravulizumab
Summary
ravulizumab is a monoclonal antibody[1]. ravulizumab ranks in the top 6% of monoclonal_antibody entities by monthly Wikipedia readership (223 views/month).[2]
Key Facts
- ravulizumab's instance of is recorded as monoclonal antibody[3].
- ravulizumab's instance of is recorded as medication[4].
- ravulizumab's legal status is recorded as boxed warning[5].
- ravulizumab's LiverTox likelihood score is recorded as LiverTox toxicity likelihood category E*[6].
Why It Matters
ravulizumab ranks in the top 6% of monoclonal_antibody entities by monthly Wikipedia readership (223 views/month).[2] ravulizumab has Wikipedia articles in 10 language editions, a strong signal of global cultural recognition.[7]